EIP Pharma reports mixed results from neflamapimod Alzheimer’s trial

Neflamapimod is being developed to treat Alzheimer’s, dementia with Lewy bodies and Huntington’s disease with cognitive dysfunction. Credit: kalhh from Pixabay.



  • EIP Pharma reports mixed results from neflamapimod trial in Alzheimer’s